Structure analysis based identification of novel anti-hiv drugs

Informations projet

N° de convention de subvention: QLK2-CT-2000-41485

Projet clôturé

Date de début 20 Decembre 2000

Date de fin 19 Decembre 2001

Financé au titre de

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Coût total € 29 500,00

Contribution de l’UE € 22 125,00

Coordonné par

STRUCTURAL BIOINFORMATICS ADVANCED TECHNOLOGIES A/S
Denmark

Objectif

The present project combines bio informatics approaches with powerful experimental techniques for revealing protein/protein interactions and the efficiency of inhibitor binding with focus on selected HIV proteins. The project includes a novel, massive use of protein structure models for determination of the structural variability of a very large number of mutants, with the aim of developing therapeutic intervention against HIV that can cope with the substantial mutation capability of the virus.

Champ scientifique

• natural sciences › biological sciences › microbiology › virology
• natural sciences › biological sciences › biochemistry › biomolecules › proteins
• medical and health sciences › health sciences › infectious diseases › RNA viruses › HIV
• natural sciences › biological sciences › genetics › mutation

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Thème(s)

• 1.1.1.-2. - Key action Control of Infectious Diseases

Appel à propositions

Data not available

Régime de financement

EAW - Exploratory awards

Coordinateur

STRUCTURAL BIOINFORMATICS ADVANCED TECHNOLOGIES A/S

• Contribution de l’UE: Aucune donnée
• Adresse: Agern Alle 3 ; 2970 HOERSHOLM ; Danemark
• Coût total: Aucune donnée

Participants (1)

HYBRIGENICS

France

• Contribution de l’UE: Aucune donnée
• Adresse: Impasse Reille 3-5 ; 75014 PARIS
• Coût total: Aucune donnée